Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Healthcare
Create a narrative
Ondine Biomedical Community
AIM:OBI Community
1
Narratives
written by author
0
Comments
on narratives written by author
0
Fair Values set
on narratives written by author
Create a narrative
Ondine Biomedical
Popular
Undervalued
Overvalued
Community Investing Ideas
Ondine Biomedical
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Mölnlycke Deal And US Trials Will Open International Markets
Key Takeaways A major partnership is expected to enhance Steriwave's market entry and international sales, boosting revenue and growth opportunities significantly. Investments in automation and funding aim to support long-term scaling and sustainable growth, improving operational efficiencies and cost management.
View narrative
UK£0.55
FV
84.5% undervalued
intrinsic discount
158.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
OBI
OBI
Ondine Biomedical
Your Fair Value
UK£
Current Price
UK£0.085
254.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-50m
26m
2015
2018
2021
2024
2025
2027
2030
Revenue CA$26.2m
Earnings CA$3.7m
Advanced
Set Fair Value